Tenecteplase vs Alteplase and Time to Treatment for Acute Ischemic Stroke

JAMA Netw Open. 2026 Jul 1;9(7):e2623260. doi: 10.1001/jamanetworkopen.2026.23260.ABSTRACTIMPORTANCE: Tenecteplase is an alternative to alteplase for intravenous thrombolysis in acute ischemic stroke given its simplified administration and comparable safety and efficacy. However, its impact on workf

S Steven J Warach

Tumescent solution for thermal ablation of lower limb varicose veins

Cochrane Database Syst Rev. 2026 Jul 13;7:CD016366. doi: 10.1002/14651858.CD016366.ABSTRACTThis is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of different tumescent solutions for adults with lower limb varicose veins undergoing

L Larissa Yt Tamada

Pre-existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18-30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data

Drugs Real World Outcomes. 2026 Jul 13. doi: 10.1007/s40801-026-00568-4. Online ahead of print.ABSTRACTBACKGROUND: Rare cases of myocarditis and pericarditis following mRNA coronavirus disease-19 (COVID-19) vaccination have been reported, primarily among males under 30 years of age. Although the und

M Mohammed Salah Salem

Extracellular Vesicles in Stroke: Drivers of Brain-Body Network Crosstalk

Transl Stroke Res. 2026 Jul 13;17(4):77. doi: 10.1007/s12975-026-01452-7.ABSTRACTMounting evidence reframes stroke not as a single cerebral event but as a dynamic brain-body network disorder. Extracellular vesicles (EVs)-lipid bilayer-enclosed particles released by virtually all cells-serve as inter

Z Zhi-Ming Xu